8-K - Amphastar Pharmaceuticals, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

On March 3, 2026, Amphastar Pharmaceuticals, Inc. entered into new executive employment agreements with Jacob Liawatidewi, Executive Vice President of Corporate Administration Center, and Rong Zhou, Senior Executive Vice President of Production Center, establishing annual base salaries of $525,800 and $590,000, respectively, along with defined severance and change-in-control provisions.

Key Takeaways

1Jacob Liawatidewi appointed with an annual base salary of $525,800 and a target bonus of 55%.

2Rong Zhou appointed with an annual base salary of $590,000 and a target bonus of 53%.

3Employment agreements have an initial one-year term with automatic successive one-year renewals.

4Qualifying terminations trigger a lump-sum payment equal to two times the sum of base salary and average bonus.

5Change-in-control provisions accelerate vesting of 100% of unvested equity awards.

6Severance benefits include up to 12 months of Company-paid health insurance premiums.

Current Report Details

Event Type

Management Change

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On Marc

Management Change

9.01

. Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 10.1 Form of Employment Agreement for Jacob Liawatidewi and Rong Zhou 104 Cover Page

Exhibits Only

Executive & Director Changes

Jacob Liawatidewi

Executive Vice President of Corporate Administration Center, Secretary and a member of the board of directors

Entered into employment agreement

Effective: 2026-03-03

Rong Zhou

Senior Executive Vice President of Production Center

Entered into employment agreement

Effective: 2026-03-03

Transaction Details

Material Agreement

Agreement: Executive Employment Agreement
Parties: Amphastar Pharmaceuticals, Inc., Jacob Liawatidewi, Rong Zhou

•Initial term of one year with automatic one-year renewals unless 90 days notice of non-renewal is given.
•Terminable by Company or executive at any time with or without cause or good reason.
•Qualifying termination (without cause or good reason resignation) provides lump-sum payment equal to two times sum of highest annual base salary in prior 12 months plus average annual bonus for most recent two fiscal years.
•Qualifying termination during change-in-control period provides additional lump-sum payment equal to two times sum of base salary plus average bonus.
•Accelerated vesting of 100% of unvested equity awards upon qualifying termination.
•Continued health insurance premium payments for up to 12 months following qualifying termination.
•Change-in-control triggers accelerated vesting of 100% of unvested equity awards.
•Parachute payment provisions apply to ensure greater after-tax amount for executive.

Exhibits (2)

10.1

EX-10.1

8-K